BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33127576)

  • 1. Comparative analysis of genome-wide DNA methylation identifies patterns that associate with conserved transcriptional programs in osteosarcoma.
    Mills LJ; Scott MC; Shah P; Cunanan AR; Deshpande A; Auch B; Curtin B; Beckman KB; Spector LG; Sarver AL; Subramanian S; Richmond TA; Modiano JF
    Bone; 2022 May; 158():115716. PubMed ID: 33127576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct mechanisms of PTEN inactivation in dogs and humans highlight convergent molecular events that drive cell division in the pathogenesis of osteosarcoma.
    Sarver AL; Mills LJ; Makielski KM; Temiz NA; Wang J; Spector LG; Subramanian S; Modiano JF
    Cancer Genet; 2023 Aug; 276-277():1-11. PubMed ID: 37267683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets.
    Hill KE; Kelly AD; Kuijjer ML; Barry W; Rattani A; Garbutt CC; Kissick H; Janeway K; Perez-Atayde A; Goldsmith J; Gebhardt MC; Arredouani MS; Cote G; Hornicek F; Choy E; Duan Z; Quackenbush J; Haibe-Kains B; Spentzos D
    J Hematol Oncol; 2017 May; 10(1):107. PubMed ID: 28506242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.
    Angstadt AY; Motsinger-Reif A; Thomas R; Kisseberth WC; Guillermo Couto C; Duval DL; Nielsen DM; Modiano JF; Breen M
    Genes Chromosomes Cancer; 2011 Nov; 50(11):859-74. PubMed ID: 21837709
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Sakthikumar S; Elvers I; Kim J; Arendt ML; Thomas R; Turner-Maier J; Swofford R; Johnson J; Schumacher SE; Alföldi J; Axelsson E; Couto CG; Kisseberth WC; Pettersson ME; Getz G; Meadows JRS; Modiano JF; Breen M; Kierczak M; Forsberg-Nilsson K; Marinescu VD; Lindblad-Toh K
    Cancer Res; 2018 Jul; 78(13):3421-3431. PubMed ID: 29724721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide DNA methylation patterns reveal clinically relevant predictive and prognostic subtypes in human osteosarcoma.
    Lietz CE; Newman ET; Kelly AD; Xiang DH; Zhang Z; Luscko CA; Lozano-Calderon SA; Ebb DH; Raskin KA; Cote GM; Choy E; Nielsen GP; Haibe-Kains B; Aryee MJ; Spentzos D
    Commun Biol; 2022 Mar; 5(1):213. PubMed ID: 35260776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma.
    Kresse SH; Rydbeck H; Skårn M; Namløs HM; Barragan-Polania AH; Cleton-Jansen AM; Serra M; Liestøl K; Hogendoorn PC; Hovig E; Myklebost O; Meza-Zepeda LA
    PLoS One; 2012; 7(11):e48262. PubMed ID: 23144859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genome-wide approach to comparative oncology: high-resolution oligonucleotide aCGH of canine and human osteosarcoma pinpoints shared microaberrations.
    Angstadt AY; Thayanithy V; Subramanian S; Modiano JF; Breen M
    Cancer Genet; 2012 Nov; 205(11):572-87. PubMed ID: 23137772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation patterns suggest the involvement of DNMT3B and TET1 in osteosarcoma development.
    Pires SF; de Barros JS; da Costa SS; de Oliveira Scliar M; Van Helvoort Lengert A; Boldrini É; da Silva SRM; Tasic L; Vidal DO; Krepischi ACV; Maschietto M
    Mol Genet Genomics; 2023 May; 298(3):721-733. PubMed ID: 37020053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling the chaotic genomic landscape of primary and metastatic canine appendicular osteosarcoma with current sequencing technologies and bioinformatic approaches.
    Chu S; Skidmore ZL; Kunisaki J; Walker JR; Griffith M; Griffith OL; Bryan JN
    PLoS One; 2021; 16(2):e0246443. PubMed ID: 33556121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive properties of DNA methylation patterns in primary tumor samples for osteosarcoma relapse status.
    Rosenblum JM; Wijetunga NA; Fazzari MJ; Krailo M; Barkauskas DA; Gorlick R; Greally JM
    Epigenetics; 2015; 10(1):31-9. PubMed ID: 25531418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-specific DNA methylation is conserved across human, mouse, and rat, and driven by primary sequence conservation.
    Zhou J; Sears RL; Xing X; Zhang B; Li D; Rockweiler NB; Jang HS; Choudhary MNK; Lee HJ; Lowdon RF; Arand J; Tabers B; Gu CC; Cicero TJ; Wang T
    BMC Genomics; 2017 Sep; 18(1):724. PubMed ID: 28899353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The degree of mitochondrial DNA methylation in tumor models of glioblastoma and osteosarcoma.
    Sun X; Vaghjiani V; Jayasekara WSN; Cain JE; St John JC
    Clin Epigenetics; 2018 Dec; 10(1):157. PubMed ID: 30558637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcoma.
    Barenboim M; Kovac M; Ameline B; Jones DTW; Witt O; Bielack S; Burdach S; Baumhoer D; Nathrath M
    PLoS Comput Biol; 2021 Nov; 17(11):e1009562. PubMed ID: 34762643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genomic landscape of canine osteosarcoma cell lines reveals conserved structural complexity and pathway alterations.
    Megquier K; Turner-Maier J; Morrill K; Li X; Johnson J; Karlsson EK; London CA; Gardner HL
    PLoS One; 2022; 17(9):e0274383. PubMed ID: 36099278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
    Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
    BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine osteosarcoma genome sequencing identifies recurrent mutations in
    Gardner HL; Sivaprakasam K; Briones N; Zismann V; Perdigones N; Drenner K; Facista S; Richholt R; Liang W; Aldrich J; Trent JM; Shields PG; Robinson N; Johnson J; Lana S; Houghton P; Fenger J; Lorch G; Janeway KA; London CA; Hendricks WPD
    Commun Biol; 2019; 2():266. PubMed ID: 31341965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-species genomics identifies DLG2 as a tumor suppressor in osteosarcoma.
    Shao YW; Wood GA; Lu J; Tang QL; Liu J; Molyneux S; Chen Y; Fang H; Adissu H; McKee T; Waterhouse P; Khokha R
    Oncogene; 2019 Jan; 38(2):291-298. PubMed ID: 30093633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional profiling of canine osteosarcoma identifies prognostic gene expression signatures with translational value for humans.
    Mannheimer JD; Tawa G; Gerhold D; Braisted J; Sayers CM; McEachron TA; Meltzer P; Mazcko C; Beck JA; LeBlanc AK
    Commun Biol; 2023 Aug; 6(1):856. PubMed ID: 37591946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: therapeutic and diagnostic clinical applications.
    Parashar S; Cheishvili D; Arakelian A; Hussain Z; Tanvir I; Khan HA; Szyf M; Rabbani SA
    Cancer Med; 2015 May; 4(5):732-44. PubMed ID: 25619880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.